Monocytes mediate HIV neuropathogenesis: Mechanisms that contribute to HIV associated neurocognitive disorders

Keyphrases

• Monocytes 100%
• HIV-associated Neurocognitive Disorders 100%
• HIV Neuropathogenesis 100%
• HIV Infection 75%
• Neuropathogenesis 75%
• HIV Patients 50%
• Virus 50%
• Blood-brain Barrier 50%
• Monocyte-derived Macrophages 50%
• Combined Antiretroviral Therapy (cART) 50%
• CD16+ Monocytes 50%
• Public Health Risk 25%
• Antiretroviral Therapy 25%
• Chemokine (C-C motif) Ligand 2 (CCL2) 25%
• Inflammatory Mediators 25%
• Macrophages 25%
• Transmigration 25%
• Neuroinflammation 25%
• Chemokine Ligand 12 (CXCL12) 25%
• Latently Infected Cells 25%
• Chronic Neuroinflammation 25%
• CD14+CD16+ 25%
• Viral Reservoir 25%
• Monocyte Transmigration 25%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• Monocyte 100%
• Macrophage 30%
• Human Immunodeficiency Virus Infection 30%
• CD14 30%
• CD16 30%
• Blood Brain Barrier 20%
• Mediator 10%
• CCL2 10%

Neuroscience

• Human Immunodeficiency Virus 100%
• HIV Associated Dementia 100%
• Macrophage 33%
• CD14 33%
• CD16 33%
• Blood Brain Barrier 22%
• CCL2 11%